- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07682441
CBITS-RTM Pilot Study
June 26, 2026 updated by: University of California, San Francisco
Preventing Substance Use Among Incarcerated Youth Through Addressing Posttraumatic Stress
This pilot study, conducted in partnership with juvenile detention centers, evaluates an adapted CBITS-RTM intervention delivered in a detention school setting.
Study Overview
Status
Not yet recruiting
Detailed Description
The study examines the intervention's feasibility and acceptability, as well as its effectiveness in reducing incarcerated youth's posttraumatic stress symptoms, improving academic functioning, and decreasing intentions to use substances post-release.
Study Type
Interventional
Enrollment (Estimated)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Johanna B Folk, PhD
- Phone Number: 415-602-9521
- Email: johanna.folk@ucsf.edu
Study Contact Backup
- Name: Jeanne McPhee, PhD
- Email: jeanne.mcphee@ucsf.edu
Study Locations
-
-
California
-
San Francisco, California, United States, 94131
- UCSF Zuckerberg San Francisco General Hospital
-
Contact:
- Principal Investigator, PhD
- Email: johanna.folk@ucsf.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Youth must 1) be currently incarcerated in a partnering juvenile detention center, 2) be between 13-18 years of age, and 3) have a minimum of 3 months remaining on their sentence (i.e., sufficient time required to complete CBITS-RTM). Youth will complete a screening with a study team member involving the 2-item Abbreviated PTSD Checklist-Civilian version, with scores ≥4 considered a positive screen
- Clinicians are eligible if they are behavioral health staff working with youth at the detention school..
Exclusion Criteria:
- Observable cognitive or developmental delays or active psychosis that would interfere with completing consent, assessment or intervention.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adapted CBITS-RTM Intervention
|
The Cognitive Behavioral Intervention for Trauma in Schools (CBITS) program is a school-based, group and individual intervention designed to reduce symptoms of post-traumatic stress disorder (PTSD), depression, and behavioral problems, and to improve functioning, grades and attendance, and coping skills.
The CBITS intervention was adapted to juvenile justice settings with an added Racial Trauma Module (RTM), which provides youth with an overview of the effects of racism on levels of traumatic stress.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Child PTSD Symptom Scale (CPSS)
Time Frame: Baseline, 3 months post-baseline
|
The CPSS is used to measure posttraumatic stress among youth (8-18 years).
It assesses past month posttraumatic stress symptom severity and impairment of endorsed symptoms on daily functioning.
Scores range from 0-80, with 31+ indicating probable PTSD.
|
Baseline, 3 months post-baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Youth Alcohol and Drug Use Survey
Time Frame: Baseline, 3 months post-baseline
|
The Youth Alcohol and Drug Use Survey will be used to gather youth's intention to use substances post-release using items rated on a scale from 1 (unlikely) to 10 (very likely).
|
Baseline, 3 months post-baseline
|
|
Texas Christian University (TCU) Drug Screen
Time Frame: Baseline, 3-months post-baseline
|
The TCU will be administered to gather information on substance use quantity and frequency as well as risk for SUD (corresponds with DSM-5 criteria) on the 3-months prior to incarceration and past 3 months at post-release.
|
Baseline, 3-months post-baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Youth Background Characteristics
Time Frame: Baseline
|
Demographics questionnaire used to gather standard demographics (e.g., age, gender, race) and information such as state agency involvement (e.g., age at first contact with juvenile legal system, number of prior arrests), immigration status.
|
Baseline
|
|
Treatment Acceptability Form
Time Frame: 3-months post-baseline
|
This form will be used to assess the acceptability of the adapted CBITS-RTM intervention.
Items are scored from 1 "Strongly disagree" to 5 "Strongly agree."
Scores range from 10-50 with higher scores indicating higher acceptability.
|
3-months post-baseline
|
|
CBITS-RTM Group Evaluation Posttest
Time Frame: 3-months post-baseline
|
This will assess knowledge of trauma, changes in ability to cope with stress, and acceptability of the intervention and its delivery.
Items are true/false or qualitative in nature.
|
3-months post-baseline
|
|
Clinician personal and background characteristics
Time Frame: Baseline
|
Questionnaire used to gather personal and professional background characteristics (e.g., clinical discipline, experience with trauma treatment, years of practice in juvenile detention setting) and assess attitudes toward evidence-based practice.
|
Baseline
|
|
Cognitive Behavioral Intervention for Trauma in Schools-Fidelity Adherence Measure 2.0
Time Frame: 20% of the sessions
|
This measure will be used to assess how closely clinicians adhere to the adapted CBITS-RTM intervention.
The measure describes in detail the core components expected to be covered in each session and the rater indicates the degree to which the content was delivered with fidelity with a score between 0-3.
|
20% of the sessions
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Johanna Folk, PhD, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
June 26, 2026
First Submitted That Met QC Criteria
June 26, 2026
First Posted (Actual)
July 2, 2026
Study Record Updates
Last Update Posted (Actual)
July 2, 2026
Last Update Submitted That Met QC Criteria
June 26, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25-45799
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use
-
University of ArkansasNational Center for Advancing Translational Sciences (NCATS)RecruitingParenting | Substance Use Treatment | Perinatal Substance UseUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Substance Use DisordersUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)CompletedSubstance Use | Opioid Use | Drug Use | Substance MisuseUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Indiana UniversityPatient-Centered Outcomes Research InstituteRecruitingAdolescent | Alcohol Use | Mild Alcohol Use Disorder | Mild Substance Use DisorderUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)Active, not recruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
University of Illinois at ChicagoNot yet recruitingHealthy | Cannabis Use | Substance Use Disorder (SUD)United States
Clinical Trials on Adapted Cognitive Behavioral Intervention for Trauma in Schools (CBITS) with a Racial Trauma Module (RTM)
-
University Hospital UlmRuhr University of Bochum; Philipps University Marburg Medical CenterNot yet recruitingPosttraumatic Stress Disorder
-
University of WashingtonNational Institute of Mental Health (NIMH); University of MinnesotaCompletedCBT | Trauma, Psychological | School Health Services | Evidence-Based PracticesUnited States